The Active Trial

• Research type

  Research Study

• Full title

  THE ACTIVE TRIAL: A Prospective Randomised Control Trial of the H1 Implant versus Total Hip Replacement

• IRAS ID

  327954

• Contact name

  Justin Cobb

• Contact email

  j.cobb@imperial.ac.uk

• Sponsor organisation

  Embody Orthopaedic Limited

• ISRCTN Number

  ISRCTN10665654

• Clinicaltrials.gov Identifier

  NCT06162195

• Duration of Study in the UK

  10 years, 6 months, 0 days

• Research summary

  The goal of this clinical investigation is to compare the success of two types of hip replacement in patients with hip arthritis. The main question it aims to answer is whether a new type of hip replacement (called a hip resurfacing) can be as successful as an existing hip replacement (called a total hip replacement). Patients will be given either the new hip resurfacing or the existing total hip replacement and researchers will compare the patients’ function, complication rate and physical activity levels.

• REC name

  Yorkshire & The Humber - Sheffield Research Ethics Committee

• REC reference

  24/YH/0083

• Date of REC Opinion

  5 Jul 2024

• REC opinion

  Further Information Favourable Opinion